<![CDATA[Insights]]>https://insights.citeline.comMon, 04 Nov 2024 10:21:23 +0000en1hourly1<![CDATA[Novo Nordisk’s Semaglutide Hits Phase III Marks In NASH]]>https://insights.citeline.com/scrip/r-and-d/clinical-trials/novo-nordisks-semaglutide-hits-phase-iii-marks-in-nash-CBI3UXYJFZDZVI4CDLTMQEU3DE/https://insights.citeline.com/scrip/r-and-d/clinical-trials/novo-nordisks-semaglutide-hits-phase-iii-marks-in-nash-CBI3UXYJFZDZVI4CDLTMQEU3DE/Fri, 01 Nov 2024 22:06:05 +0000<![CDATA[UCB Weighs Up Alzheimer’s Drug Future After Phase II Miss And Roche Exit]]>https://insights.citeline.com/scrip/r-and-d/clinical-trials/ucb-weighs-up-alzheimers-drug-future-after-phase-ii-miss-and-roche-exit-XIWAX7VJZZEDRMM6IUV4KGURAA/https://insights.citeline.com/scrip/r-and-d/clinical-trials/ucb-weighs-up-alzheimers-drug-future-after-phase-ii-miss-and-roche-exit-XIWAX7VJZZEDRMM6IUV4KGURAA/Fri, 01 Nov 2024 17:09:24 +0000